VeraQ’s powerful capabilities help you generate real-world evidence, advance treatment insights, enable quality measurement reports, enhance patient recruitment and engagement, and reduce trial costs.
San Antonio, January 11, 2023 /PRNewswire/ — Recently, Frost & Sullivan Analyzes the Real World Evidence (RWE) Solutions industry and, based on its findings, Verana Health® Winner of the 2022 North American New Product Innovation Award. The digital health company uniquely leverages its expertise to address a currently unmet market need and solidify its leadership in the RWE solutions space. Provides high-quality drug lifecycle and clinical practice insights from real-world data (RWD), exclusively commissioned by Verana Health from leading specialties. medical societyenabling you to manage anonymized data from over 20,000 medical clinicians and over 70 electronic health record (EHR) systems.
2022 North American Real-World Evidence Solutions New Product Innovation Award
Verana Health’s VeraQ® Population Health Data Engine transforms structured and unstructured EHR data into curated quality data (Qdata®) that analyzes quality of care, treatment patterns and outcomes, clinical trial site selection, and treatment markets. Enhanced insights on shares and more. This engine has anonymized his EHR from his three unparalleled databases: the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight), the American Urological Association Quality Registry (AQUA), and the American Academy of Neurology Axon Registry Ingest and curate data. We then often link the anonymized data to other sources such as medical and pharmacy claims, diagnostic imaging, genomics, and mortality data. Verana Health uses clinician supervision, natural language processing, and machine learning to maintain, protect, and curate its data ecosystem. It also provides closer to real-time insight into the entire drug lifecycle. This platform leverages the following information:
- Over 500 million patient visits
- 20,000+ Contributing Clinicians
- Long-term data over 9 years
- About 90 million anonymized patients
- Over 70 contributed EHR systems
- 3 therapeutic areas
Unmesh Ral“Information technology solution providers are looking to create and extract value from increasing RWD volumes to enhance patient recruitment and engagement and reduce clinical trial costs,” said Frost & Sullivan, Research Director, Healthcare Specialist. We are reducing clinical trials and increasing the number of longitudinal trials and digital patient data.”
VeraQ has created a purpose-curated data module called Qdata to help answer complex questions that require observational input from anonymized clinician notes and EHR records. VeraQ is the foundation for quality insights from her RWD across clinical studies. Her Qdata in ophthalmology, urology, and neurology enhances observational research studies and helps identify potential patient cohorts for clinical trials to accelerate trial activity.
“Verana Health has developed a Life Sciences lifecycle solutions model from clinical development to market expansion. I will make it possible,” he added. Manuel Albornoz, Frost & Sullivan Best Practices Research Analyst. Verana Health has been awarded Frost & Sullivan’s 2022 North American New Product Innovations for his leadership in the RWE solutions industry for his excellent overall performance.
Frost & Sullivan presents this award each year to companies that utilize cutting-edge technology to develop innovative elements in their products. This award recognizes a product’s value-added features/benefits and the increased return on investment (ROI) it provides to customers, increasing their potential for customer acquisition and overall market penetration.
The Frost & Sullivan Best Practices Awards recognize companies in various regional and global markets for outstanding performance and outstanding performance in leadership, innovation, customer service and strategic product development. Industry analysts compare market participants, measure performance through in-depth interviews, analysis and extensive secondary research, and identify industry best practices.
About Frost & Sullivan
For 60 years, Frost & Sullivan has helped investors, business leaders, and governments navigate economic change and identify disruptive technologies, megatrends, new business models, and companies to take action. He was world-renowned for his support. Drive future success. inquiry: start a discussion.
About Velana Health
Verana Health® is a digital health company that improves the quality of real-world data. Verana Health has exclusive access to more than 20,000 healthcare providers (HCPs) and approximately 90 million anonymized patients derived from strategic data partnerships with the American Academy of Ophthalmology®, the American Academy of Neurology, and American Urological operates a real-world data network. Association. Verana Health informs clinicians and transforms structured and unstructured health data into curated, high-quality data modules, Qdata®, using the artificial intelligence-enhanced VeraQ® population health data engine. Convert. Verana Health’s Qdata helps power analytics solutions and software-as-a-service products for real-world evidence generation, clinical trial validation, HCP quality reporting, and healthcare registry data management. Verana Health’s high-quality data and insights help advance medical progress and improve the quality of care and quality of life for patients. For more information, please visit www.veranahealth.com.
contact:
Claudia Toscano
Phone: +1.210.477.8417
E: [email protected]
Photo – https://mma.prnewswire.com/media/1981095/Verana_Health_Award.jpg
Sauce Frost & Sullivan
